Biphenyl

Biphenyl

SCHEMBL418438

c1ccc(-c2ccccc2)cc1.c1ccc(-c2ccccc2)cc1.c1ccc(-c2ccccc2)cc1.c1cnnnc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
NOTUM Q6P988 2/20 0.55
ATM Q13315 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL790630 1.00 ALDH1A1 (0.56) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL790623 1.00 ALDH1A1 (0.56) ALDH1A1NOTUMATMRAB9ANPC1
SCHEMBL28449767 0.89 NISCH (0.47) ALDH1A1NOTUMNPC1GABRA1GABRG2
Biphenyl SCHEMBL4430627 0.87 MMP3 (0.56) ALDH1A1NOTUMRAB9ANPC1CYP3A4
SCHEMBL2920544 0.86 NISCH (0.45) ALDH1A1NOTUMMAPK1SMN1; SMN2HSD17B10
SCHEMBL16294953 0.86 NISCH (0.45) ALDH1A1NOTUMMAPK1SMN1; SMN2HSD17B10
Biphenyl SCHEMBL16469972 0.85 L3MBTL1 (0.52) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl-4-Amine SCHEMBL29066153 0.85 CYP3A4 (0.68) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL27478909 0.84 ALDH1A1 (0.60) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL27722886 0.83 ALDH1A1 (0.82) ALDH1A1NOTUMATMRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144741-A1 NOVEL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2026-05-28 US claimed
EP-4103144-B1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2026-05-27 EP claimed
US-20260137611-A1 NOVEL COMPOSITIONS DSM IP ASSETS B V (NL) 2026-05-21 US claimed
WO-2026099270-A1 BIODEGRADABLE UV ABSORBERS AND USES THEREOF II BASF SE (DE) 2026-05-15 WO claimed
WO-2026087604-A1 ECOBIOLOGICAL COMPOSITION COMPRISING ENVIRONMENTALLY FRIENDLY SUN PROTECTION BOOSTERS NAOS INSTITUTE OF LIFE SCIENCE (FR) 2026-04-30 WO claimed
US-20260108435-A1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS SAES GETTERS S.P.A. (IT) 2026-04-23 US claimed
US-20260108436-A1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS SAES GETTERS S.P.A. (IT) 2026-04-23 US claimed
EP-4724029-A1 LOW PENETRATION SUNSCREEN COMPOSITIONS Kenvue Brands LLC (US) 2026-04-15 EP claimed
EP-4721722-A1 COSMETIC COMPOSITION EXHIBITING EXCELLENT BLOCKING EFFICACY AGAINST HARMFUL RAYS INCLUDING ULTRAVIOLET RADIATION Kolmar Korea Co., Ltd. (KR) 2026-04-08 EP claimed
EP-4518849-B1 COMPOSITION FOR TOPICAL APPLICATION FOR THE PHOTOTHERAPEUTIC TREATMENT OF INFLAMMATORY-BASED SKIN DISEASES GIULIANI SPA (IT) 2026-04-08 EP claimed
WO-2016176633-A1 SILK-BASED MOISTURIZER COMPOSITIONS AND METHODS THEREOF Silk Therapeutics, Inc. (US) 2016-11-03 WO claimed
EP-3082974-A1 CARRIER SYSTEM FOR WATER-SOLUBLE ACTIVE INGREDIENTS L'OREAL (FR) 2016-10-26 EP claimed
WO-2015095711-A1 CARRIER SYSTEM FOR WATER-SOLUBLE ACTIVE INGREDIENTS L'OREAL (FR) 2015-06-25 WO claimed
US-20150174046-A1 PHOTOPROTECTION COMPOSITION CONTAINING HIGH LEVELS OF WATER-SOLUBLE UV FILTERS L'OREAL (FR) 2015-06-25 US claimed
US-20150056150-A1 COMPOSITION AND ASSOCIATION OF SUNSCREENS FOR PHOTOSTABILIZING BUTYL METHOXYDIBENZOYLMETHANE (BMDBM) PIERRE FABRE DERMO-COSMETIQUE (FR) 2015-02-26 US claimed
US-20150050223-A1 NOVEL PHOTOPROTECTIVE SYSTEM PIERRE FABRE DERMO COSMETIQUE (FR) 2015-02-19 US claimed
EP-2809297-A2 NOVEL PHOTOPROTECTIVE SYSTEM Pierre Fabre Dermo-Cosmétique (FR) 2014-12-10 EP claimed
EP-2809295-A2 COMPOSITION AND ASSOCIATION OF SUNSCREENS FOR PHOTOSTABILIZING BUTYL METHOXYDIBENZOYLMETHANE (BMDBM) Pierre Fabre Dermo-Cosmétique (FR) 2014-12-10 EP claimed
WO-2013113745-A2 NOVEL PHOTOPROTECTIVE SYSTEM PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-08-08 WO claimed
WO-2013113746-A2 COMPOSITION AND COMBINATION OF BMDBM PHOTOSTABILIZERS AND SUNSCREENS PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-08-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108435-A1 SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS SOD1, MCM5, GSTM1 ALDH1A1 3122/4885NOTUM 830/4885ATM 535/4885
US-20260137611-A1 NOVEL COMPOSITIONS SSB, BRCA1, TYR ALDH1A1 4419/4885NOTUM 2802/4885ATM 1114/4885
US-20260144741-A1 NOVEL COMPOSITIONS BRCA1, DSG1, MUC1 ALDH1A1 1877/4885NOTUM 2440/4885ATM 319/4885
US-20260108436-A1 SUNSCREEN COMPOSITION WITH SPF BOOSTERS BRCA1, SQOR, NDUFB5 ALDH1A1 457/4885NOTUM 729/4885ATM 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.